ICH Q8 Pharmaceutical Development

E131967

ICH quality guideline pharmaceutical guideline regulatory guidance document

ICH Q8 Pharmaceutical Development is an international guideline that outlines a systematic, science- and risk-based approach to pharmaceutical product and process development, forming a core part of the ICH quality framework.

Try in SPARQL Jump to: Surface forms Statements Referenced by

All labels observed (2)

Label	Occurrences
ICH Q8 Pharmaceutical Development canonical	6
ICH Q8	1

Statements (47)

Predicate	Object
instanceOf	ICH quality guideline ⓘ pharmaceutical guideline ⓘ regulatory guidance document ⓘ
aimsTo	improve product quality consistency ⓘ reduce manufacturing variability ⓘ
appliesTo	marketing authorization applications ⓘ new drug applications ⓘ pharmaceutical products for human use ⓘ
documentType	harmonised tripartite guideline ⓘ
emphasizes	risk-based development ⓘ science-based development ⓘ systematic approach to development ⓘ
encourages	use of design of experiments ⓘ use of prior knowledge in development ⓘ use of risk management tools ⓘ
focusesOn	pharmaceutical development ⓘ process development ⓘ product development ⓘ
formsPartOf	ICH quality by design framework ⓘ
guides	establishment of control strategy ⓘ selection of formulation components ⓘ selection of manufacturing process ⓘ
hasAbbreviation	ICH Q8 Pharmaceutical Development self-linksurface differs ⓘ surface form: ICH Q8
hasSection	compatibility of drug product with diluents or co-administered products ⓘ container closure system ⓘ drug product development ⓘ manufacturing process development ⓘ microbiological attributes ⓘ pharmaceutical development report ⓘ
introducesConcept	control strategy ⓘ critical process parameters ⓘ critical quality attributes ⓘ design space ⓘ
issuedBy	International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use ⓘ
objective	to enhance understanding of product and process ⓘ to facilitate more flexible regulatory approaches ⓘ
partOf	International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use ⓘ surface form: International Council for Harmonisation quality guidelines
regionImplementedIn	European Union ⓘ Japan ⓘ United States of America ⓘ surface form: United States
relatedTo	ICH Q10 Pharmaceutical Quality System ⓘ ICH Q11 Development and Manufacture of Drug Substances ⓘ ICH Q9 Quality Risk Management ⓘ
scopeIncludes	biotechnological/biological products ⓘ chemical drug products ⓘ
supports	lifecycle management of pharmaceutical products ⓘ
supportsConcept	quality by design ⓘ

How these facts were elicited

The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.

Instruction

You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10.

# Requirements
- If you don't know the subject at all, return an empty list.
- If the subject is not a named entity, return an empty list.
- Include at least one triple where predicate is "instanceOf".
- Do not get too wordy.
- Separate several objects into multiple triples with one object.

Input

Subject: ICH Q8 Pharmaceutical Development
Description of subject: ICH Q8 Pharmaceutical Development is an international guideline that outlines a systematic, science- and risk-based approach to pharmaceutical product and process development, forming a core part of the ICH quality framework.

Referenced by (7)

Full triples — surface form annotated when it differs from this entity's canonical label.

International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use → notableWork → ICH Q8 Pharmaceutical Development ⓘ

ICH → notableGuideline → ICH Q8 Pharmaceutical Development ⓘ

ICH Q8 Pharmaceutical Development → hasAbbreviation → ICH Q8 Pharmaceutical Development self-linksurface differs ⓘ

this entity surface form: ICH Q8

ICH Q9 Quality Risk Management → supports → ICH Q8 Pharmaceutical Development ⓘ

ICH Q10 Pharmaceutical Quality System → basedOn → ICH Q8 Pharmaceutical Development ⓘ

ICH Q10 Pharmaceutical Quality System → supports → ICH Q8 Pharmaceutical Development ⓘ

ICH Q10 Pharmaceutical Quality System → alignedWith → ICH Q8 Pharmaceutical Development ⓘ